{"id":11248,"date":"2019-07-26T00:00:00","date_gmt":"2019-07-26T05:00:00","guid":{"rendered":"https:\/\/myeloma.ca\/1970\/01\/01\/darzalex-approuve-en-saskatchewan\/"},"modified":"2025-08-19T08:28:21","modified_gmt":"2025-08-19T13:28:21","slug":"darzalex-approuve-en-saskatchewan","status":"publish","type":"post","link":"https:\/\/myeloma.ca\/fr\/2019\/07\/26\/darzalex-approuve-en-saskatchewan\/","title":{"rendered":"DARZALEX APPROUV\u00c9 EN SASKATCHEWAN!"},"content":{"rendered":"<p>Depuis le 15 juillet, en Saskatchewan, Darzalex (daratumumab) a \u00e9t\u00e9 approuv\u00e9 en association avec le l\u00e9nalidomide et la dexam\u00e9thasone (DRd) ou avec le bortezomib et la dexam\u00e9thasone (DVd) pour le traitement des patients atteints d\u2019un my\u00e9lome multiple ayant re\u00e7u au moins un traitement pr\u00e9c\u00e9dent et ayant de bons r\u00e9sultats.<\/p>\n<p><a href=\"http:\/\/www.saskcancer.ca\/Formulary%2007-2019\" target=\"_blank\" rel=\"noopener\">Consulter la circulaire <\/a>(en anglais)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Depuis le 15 juillet, en Saskatchewan, Darzalex (daratumumab) a \u00e9t\u00e9 approuv\u00e9 en association avec le l\u00e9nalidomide et la dexam\u00e9thasone (DRd) ou avec le bortezomib et la dexam\u00e9thasone (DVd) pour le traitement des patients atteints d\u2019un my\u00e9lome multiple ayant re\u00e7u au moins un traitement pr\u00e9c\u00e9dent et ayant de bons r\u00e9sultats. Consulter la circulaire (en anglais)<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[53,50,58,52],"tags":[],"class_list":["post-11248","post","type-post","status-publish","format-standard","hentry","category-actualites-et-evenement","category-news-events","category-nouvelles-de-myelome-canada","category-whats-new-at-myeloma-canada"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11248","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/comments?post=11248"}],"version-history":[{"count":1,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11248\/revisions"}],"predecessor-version":[{"id":31326,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11248\/revisions\/31326"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=11248"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/categories?post=11248"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/tags?post=11248"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}